1 Min Read
June 8 (Reuters) - Qiagen NV:
* Qiagen’s Quantiferon®-Tb Gold plus gains U.S. FDA approval
* Qiagen Nv - U.S. Commercialization of Quantiferon®-Tb Gold Plus is planned to begin later this year Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.